Ibrutinib (PCI-32765)

Suppliers

Names

[ CAS No. ]:
936563-96-1

[ Name ]:
Ibrutinib (PCI-32765)

[Synonym ]:
1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one
Imbruvica
PCI 32765
CRA-032765
1-{(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl}-2-propen-1-one
PCI-32765
2-Propen-1-one, 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-
PCI-32765-00
Ibrutinib
2-​Propen-​1-​one, 1-​[(3R)​-​3-​[4-​amino-​3-​(4-​phenoxyphenyl)​-​1H-​pyrazolo[3,​4-​d]​pyrimidin-​1-​yl]​-​1-​piperidinyl]​-

Chemical & Physical Properties

[ Density]:
1.3±0.1 g/cm3

[ Boiling Point ]:
715.0±60.0 °C at 760 mmHg

[ Molecular Formula ]:
C25H24N6O2

[ Molecular Weight ]:
440.497

[ Flash Point ]:
386.2±32.9 °C

[ Exact Mass ]:
440.196075

[ PSA ]:
99.16000

[ LogP ]:
2.92

[ Vapour Pressure ]:
0.0±2.3 mmHg at 25°C

[ Index of Refraction ]:
1.696

[ Storage condition ]:
-20°C


Related Compounds

  • PCI-32765 (Racemate)
  • Ibrutinib-MPEA
  • IbrutinibImpurity15(IbrutinibImpurity)
  • Ibrutinib deacryloylpiperidine
  • Ibrutinib Impurity 28
  • Ibrutinib-d5
  • 3-[N-ethyl-4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)hexanamido]-2-methylpropanoic acid
  • tert-butyl N-(3,3-difluoro-4-hydroxy-2,5,5-trimethylhexan-2-yl)carbamate
  • Ethyl 2-[(4-iodophenyl)amino]pyridine-3-carboxylate
  • Ethyl 3-[(2-aminoethyl)amino]benzoate
  • 4-cyclopentyl-5-ethyl-4H-1,2,4-triazole-3-sulfonyl chloride
  • N-[(4-ethylphenyl)methyl]-N-methylhydroxylamine
  • 1-(2-Isocyanatopropan-2-yl)-2-methoxy-4-methylbenzene
  • 3-[(7-Chloro-1,3-dioxaindan-5-yl)methyl]piperidin-3-ol
  • rac-1-[(1R,3S)-3-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]-2,2-difluorocyclopropanecarbonyl]-2-methylpyrrolidine-3-carboxylic acid
  • 2-[(1-Acetylpyrrolidin-3-yl)amino]acetic acid hydrochloride
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.